Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy

[1]  Virginia M. Y. Lee,et al.  High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease Tauopathies , 2020, Neuron.

[2]  Jeannie-Marie S. Leoutsakos,et al.  Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T. , 2020, Journal of affective disorders.

[3]  P. Oliver,et al.  ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease , 2020, Antioxidants.

[4]  N. Toni,et al.  Neuronal metabolic rewiring promotes resilience to neurodegeneration caused by mitochondrial dysfunction , 2020, Science Advances.

[5]  John L. Robinson,et al.  Distribution patterns of tau pathology in progressive supranuclear palsy , 2020, Acta Neuropathologica.

[6]  D. Dwivedi,et al.  Glutathione in Brain: Overview of Its Conformations, Functions, Biochemical Characteristics, Quantitation and Potential Therapeutic Role in Brain Disorders , 2020, Neurochemical Research.

[7]  G. Remington,et al.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study , 2019, Neuropsychopharmacology.

[8]  P. Mandal,et al.  Quantitation of in vivo brain glutathione conformers in cingulate cortex among age‐matched control, MCI, and AD patients using MEGA‐PRESS , 2019, Human brain mapping.

[9]  A. Parker,et al.  Comparison of Neurochemical and BOLD Signal Contrast Response Functions in the Human Visual Cortex , 2019, The Journal of Neuroscience.

[10]  T. Obata,et al.  Association between Brain and Plasma Glutamine Levels in Healthy Young Subjects Investigated by MRS and LC/MS , 2019, Nutrients.

[11]  Jun‐Seok Lee,et al.  Crosstalk between Oxidative Stress and Tauopathy , 2019, International journal of molecular sciences.

[12]  A. Aleman,et al.  Lateral parietal cortex in the generation of behavior: implications for apathy , 2019, Progress in Neurobiology.

[13]  Anke Henning,et al.  Methodological consensus on clinical proton MRS of the brain: Review and recommendations , 2019, Magnetic resonance in medicine.

[14]  Steve W. C. Chang,et al.  From Stress to Anhedonia: Molecular Processes through Functional Circuits , 2019, Trends in Neurosciences.

[15]  Clay B. Holroyd,et al.  Brain mechanisms underlying apathy , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[16]  S. Starkstein,et al.  The neuroimaging basis of apathy: Empirical findings and conceptual challenges , 2018, Neuropsychologia.

[17]  Ming-Rong Zhang,et al.  Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  S. A. Wijtenburg,et al.  Glutamatergic metabolites among adolescents at risk for psychosis , 2017, Psychiatry Research.

[19]  Yang Zhang,et al.  Brain gray matter abnormalities in progressive supranuclear palsy revisited , 2017, Oncotarget.

[20]  Keith A. Johnson,et al.  Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease. , 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[21]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[22]  Takashi Kato,et al.  Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Rupert Lanzenberger,et al.  Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology , 2017, The Journal of Nuclear Medicine.

[24]  John L. Robinson,et al.  Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases , 2017, Journal of neuropathology and experimental neurology.

[25]  P. Leigh,et al.  Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[26]  Peter Jezzard,et al.  Advanced processing and simulation of MRS data using the FID appliance (FID‐A)—An open source, MATLAB‐based toolkit , 2017, Magnetic resonance in medicine.

[27]  J. Rowe,et al.  Managing cognition in progressive supranuclear palsy , 2016, Neurodegenerative disease management.

[28]  U. Sengupta,et al.  Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases , 2016, Journal of Alzheimer's disease : JAD.

[29]  Ciprian Catana,et al.  Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging , 2016, NeuroImage.

[30]  S. Rauch,et al.  LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER. , 2016, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[31]  Ashley D Harris,et al.  Tissue correction for GABA‐edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations , 2015, Journal of magnetic resonance imaging : JMRI.

[32]  N. Soussi-Yanicostas,et al.  Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies? , 2015, Oxidative medicine and cellular longevity.

[33]  Naruhiko Sahara,et al.  “Tau Oligomers,” What We Know and What We Don’t Know , 2014, Front. Neurol..

[34]  G. Barker,et al.  Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders , 2013, Journal of Neurology.

[35]  M. Sofroniew.  Molecular dissection of reactive astrogliosis and glial scar formation , 2009, Trends in Neurosciences.

[36]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[37]  B. Biswal,et al.  Functional connectivity of default mode network components: Correlation, anticorrelation, and causality , 2009, Human brain mapping.

[38]  Xiongwei Zhu,et al.  Antioxidant therapy in Alzheimer's disease: theory and practice. , 2008, Mini reviews in medicinal chemistry.

[39]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[40]  A. Lees,et al.  Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.

[41]  B. Dubois,et al.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. , 2006, Cerebral cortex.

[42]  H. Fukuyama,et al.  Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease , 2004, Journal of the Neurological Sciences.

[43]  S. Kish,et al.  Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[44]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[45]  Richard G. Brown,et al.  Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour , 2000, Trends in Neurosciences.

[46]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[47]  R. Robinson,et al.  Apathy Following Cerebrovascular Lesions , 1993, Stroke.